Company Details

Fund type

VC (corporate holding structure)

Team size

6

HQ location

Luxembourg & Hong Kong

Other offices

Beijing

VC advisor team

Various experienced MedTech and Mobility executives with decades of experience across Europe, the US and Asia

VC classification​

Cross-border VC (Europe and Asia)

INVESTMENT SCOPE

Investment stages

Seed, Series A

Average ticket size

EUR 2-4 million, with flexibility

Startup geography

Europe, Israel and Asia

EU impact classification

Article 8 - Promoting ESG

Verticals and technologies

Medtech and Mobility

Ascend Capital Partners

Investing in early-stage Medtech and Mobility companies in Europe and Asia

About

VC investing in early-stage Medtech and Mobility companies in Europe and Asia, providing hands-on support to expand into Asian, Europa and US.

Portfolio

Portfolio size

7

Annual investments

2-4

Exits

Grundium (PE buy-out, May-22), Aiforia (IPO, Dec-21), IEE (Trade sale, Jan-13), NVC Lighting (HK IPO), TCT Medical (Trade sale), Acorn International (Nasdaq IPO), Bioregen (PE buy-out), China Autoparts (PE buy-out)

Active Funds

Fund

1
  • Launch year:
2017
  • Size (AUM):
EUR 34 million
  • Investor involvement:
Majority partner-funded, with outside participation from HNWs and family offices
  • Fund management location:
Luxembourg and Hong Kong

Nordic Connection & Vision

Our vision is for early-stage tech entrepreneurs to realise their full potential by supporting them to capture significant market opportunities in Asia, a geography which they may admire but not have much knowledge, experience or connections to address and, crucially, unlock hidden value in their businesses. We provide close support for our portfolio companies through our active investment approach, bringing financial and industry expertise to bear, as well as connections which blossom into commercial opportunities that accelerate growth. We closely guide entrepreneurs into the market, looking to deepen our strategic support by offering localisation opportunities in Asia, such as setting up local joint ventures and operations. We are a financial investor with a strategic mindset.

Our current portfolio is spread across Europe and Asia, with a strong track record of implementing our successful thesis through them.

All of our partners have substantial experience working in and/or cultural links with Asia, as well as Europe.

INVESTOR COLLABORATION

  • Lead investments:

Yes (e.g. Canatu, TactoTek, Grundium, Aiforia)

  • Syndicate investments:

Yes

  • Follow investments:

Yes

UPCOMING FUND

Fund size

EUR 60-80 million

Fund thesis

Investing in European high-tech early-stage medtech and mobility tech firms, supporting them to grow in Asia/US, as well as Asian companies and growth in Europe/US

Closing date

Q4 2022

GET IN TOUCH WITH

Ascend Capital Partners